Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state

Sophia R Newcomer, Rain E Freeman, Alexandria N Albers, Sara Murgel, Juthika Thaker, Annie Rechlin, Bekki K Wehner, Sophia R Newcomer, Rain E Freeman, Alexandria N Albers, Sara Murgel, Juthika Thaker, Annie Rechlin, Bekki K Wehner

Abstract

Human papillomavirus (HPV) vaccination rates are lower in rural versus urban areas of the United States. Our objective was to identify the types of vaccination clinic settings where missed opportunities for HPV vaccine series initiation most frequently occurred in Montana, a large, primary rural U.S. state. We analyzed a limited dataset from Montana's immunization information system for adolescents who turned 11 years old in 2014-2017. Vaccination visits where the HPV vaccine was due but not administered were missed opportunities. We compared missed opportunities across six types of clinic settings, and calculated adjusted relative risks (RR) using a generalized estimating equation model. Among n = 47,622 adolescents, 53.9% of 71,447 vaccination visits were missed opportunities. After adjusting for sex, age, and rurality of clinic location, receiving vaccines in public health departments was significantly associated with higher risk of missed opportunities (aRR = 1.25, 95% confidence interval = 1.22-1.27, vs. private clinics). Receipt of vaccines in Indian Health Services and Tribal clinics was associated with fewer missed opportunities (aRR = 0.72, 95% CI: 0.69-0.75, vs. private clinics). Our results indicate the need for interventions to promote HPV vaccine uptake in public health departments, which are a critical source of immunization services in rural and medically underserved areas of the U.S.

Keywords: Vaccination; adolescent health; human papillomavirus vaccine; immunization information systems; rural health.

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

References

    1. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL.. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med. 2011;53(Suppl 1):S12–5. doi:10.1016/j.ypmed.2011.08.017. PMID: 21962466.
    1. Centers for Disease Control and Prevention (CDC) . Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–08. PMID: 22189893. [accessed 2021 Aug 9].
    1. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–08. doi:10.15585/mmwr.mm6549a5. PMID: 27977643.
    1. Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 Years - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1109–16. doi:10.15585/mmwr.mm6933a1. PMID: 32817598.
    1. Williams CL, Walker TY, Elam-Evans LD, Yankey D, Fredua B, Saraiya M, Stokley S. Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016-2017. Hum Vaccin Immunother. 2020;16(3):562–72. doi:10.1080/21645515.2019.1670036. PMID 31584312.
    1. National Cancer Institute . HPV vaccination for cancer prevention: progress, opportunities, and a renewed call to action. A report to the president of the United States from the chair of the President’s Cancer Panel. 2018. Nov [accessed 2021 Aug 9]. .
    1. Groom H, Hopkins DP, Pabst LJ, Murphy Morgan J, Patel M, Calonge N, Coyle R, Dombkowski K, Groom AV, Kurilo MB, et al. Immunization information systems to increase vaccination rates: a community guide systematic review. J Public Health Manag Pract. 2015;21(3):227–48. PMID: 24912082. doi:10.1097/PHH.0000000000000069.
    1. Scharf LG, Coyle R, Adeniyi K, Fath J, Harris L, Myerburg S, Kurilo MB, Abbott E. Current challenges and future possibilities for immunization information systems. Acad Pediatr. 2021;21(4S):S57–S64. doi:10.1016/j.acap.2020.11.008. PMCID: PMC8112731.
    1. United States Census Bureau . Metropolitan and micropolitan statistical areas map (March 2020). 2020. Nov 4 [accessed 2021 Aug 9]. .
    1. Centers for Medicare & Medicaid Services . Rural health clinics. Baltimore (MD): Centers for Medicare & Medicaid Services; 2020. Feb 11. [accessed 2021 Aug 9].
    1. United States Census Bureau . Montana. Suitland (MD): United States Census Bureau; 2020. [accessed 2021 Oct 3]. .
    1. Indian Affairs . Tribal Nations. Helena (MT): Governor’s Office of Indian Affairs. n.d.. [accessed 2021 Oct 3]. .
    1. Wallace-Brodeur R, Li R, Davis W, Humiston S, Albertin C, Szilagyi PG, Rand CM. A quality improvement collaborative to increase human papillomavirus vaccination rates in local health department clinics. Prev Med. 2020;139:106235. doi:10.1016/j.ypmed.2020.106235. PMID: 32800972.
    1. Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, Asafu-Adjei JK, Szilagyi PG. Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev. 2018;1(1):CD003941. doi:10.1002/14651858.CD003941.pub3. PMCID: PMC6491344.
    1. Vinci DM, Ryan J, Howard M, Snider D, Strahan B, Smith G, McClain R. Increasing human papillomavirus vaccination in a federally qualified health center organization using a systems-based intervention integrating EHR and statewide immunization information system [published online ahead of print. J Community Health. 2021. Jul 31. doi:10.1007/s10900-021-00965-6. PMID: 34333719.
    1. Oltean HN, Lofy KH, Goldoft MJ, DeBolt CA. Human papillomavirus vaccination in Washington state: estimated coverage and missed opportunities, 2006–2013. Public Health Rep. 2016;131(3):474–82. doi:10.1177/003335491613100313. PMCID: PMC4869078.
    1. Kepka D, Spigarelli MG, Warner EL, Yoneoka Y, McConnell N, Balch A. Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data. Papillomavirus Res. 2016;2:128–32. doi:10.1016/j.pvr.2016.06.002. PMCID: PMC4985178.
    1. Enujioke SC, Shedd-Steele R, Daggy J, Burney H, Robertson L, Head K, Zimet G. County-level correlates of missed opportunities for HPV vaccination in Indiana: an environmental scan. Vaccine. 2020;38(43):6730–34. doi:10.1016/j.vaccine.2020.08.048. Epub 2020 Sep 3. PMCID: PMC7774590.
    1. Reiter PL, Gerend MA, Gilkey MB, Perkins RB, Saslow D, Stokley S, Tiro JA, Zimet GD, Brewer NT. Advancing human papillomavirus vaccine delivery: 12 priority research gaps. Acad Pediatr. 2018;18(2S):S14–S16. doi:10.1016/j.acap.2017.04.023. PMCID: PMC5848504.
    1. Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764. doi:10.1542/peds.2016-1764. PMCID: PMC5192091.
    1. Gilkey MB, McRee AL. Provider communication about HPV vaccination: a systematic review. Hum Vaccin Immunother. 2016;12(6):1454–68. doi:10.1080/21645515.2015.1129090. PMID: 26838681.
    1. Stewart AM, Lindley MC, Cox MA. State law and standing orders for immunization services. Am J Prev Med. 2016;50(5):e133–e142. doi:10.1016/j.amepre.2015.10.003. PMCID: PMC4841732.
    1. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752. PMCID: PMC4538997.
    1. Newcomer SR, Caringi J, Jones B, Coyle E, Schehl T, Daley MF. A mixed-methods analysis of barriers to and facilitators of human papillomavirus vaccination among adolescents in Montana. Public Health Rep. 2020;135(6):842–50. doi:10.1177/0033354920954512. PMID: 32972304.
    1. Niccolai LM, Hansen CE. Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review. JAMA Pediatr. 2015;169(7):686–92. doi:10.1001/jamapediatrics.2015.0310. PMCID: PMC4862306.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner